I guess everyone missed this
During the fiscal year ended June 30, 2017, we consolidated the accounts of EcoGen in our financial statements as we continue to exercise greater influence over EcoGen’s business affairs. At September 30, 2017, we now own 75% of the common stock of EcoGen. As of September 30, 2017, we have approximately $450,000 ($420,000 net of accumulated amortization) in intangible assets related to licenses held by EcoGen. Such intangible assets are being amortized over an estimated useful life of 20 years, except for approximately $50,000 in licenses associated with certain pharmaceutical products which do not expire and are considered to have an indefinite life. This allocation to intangible assets is preliminary and may be adjusted as we complete the evaluation of EcoGen assets.